<?xml version="1.0" encoding="UTF-8"?>
<p id="Par21">Although the predominant clinical manifestation of COVID-19 is viral pneumonia
 <sup>
  <xref ref-type="bibr" rid="CR1">1</xref>,
  <xref ref-type="bibr" rid="CR2">2</xref>,
  <xref ref-type="bibr" rid="CR48">48</xref>,
  <xref ref-type="bibr" rid="CR49">49</xref>
 </sup>, COVID-19 can also cause cardiovascular disorders such as myocardial injury, arrhythmias, ACS and thromboembolism
 <sup>
  <xref ref-type="bibr" rid="CR12">12</xref>–
  <xref ref-type="bibr" rid="CR15">15</xref>
 </sup> (Fig. 
 <xref rid="Fig2" ref-type="fig">2</xref>). Some patients who present without the typical symptoms of fever or cough have cardiac symptoms as the first clinical manifestation of COVID-19 (refs
 <sup>
  <xref ref-type="bibr" rid="CR52">52</xref>,
  <xref ref-type="bibr" rid="CR53">53</xref>
 </sup>). Myocardial injury during the course of COVID-19 is independently associated with high mortality
 <sup>
  <xref ref-type="bibr" rid="CR23">23</xref>
 </sup>. Furthermore, a possible link between COVID-19 and a Kawasaki disease-like syndrome has been described in children
 <sup>
  <xref ref-type="bibr" rid="CR26">26</xref>
 </sup>.
</p>
